# A Study to Assess the Impact and Adverse Events of Topical Eyedrops of AGN-190584 on Night-driving Performance in Participants, 40 to 55 Years of Age

> **NCT04837482** · PHASE3 · COMPLETED · sponsor: **AbbVie** · enrollment: 43 (actual)

## Conditions studied

- Presbyopia

## Interventions

- **DRUG:** AGN-190584
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT04837482
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-14
- **Primary completion:** 2021-12-07
- **Final completion:** 2021-12-07
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2024-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04837482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04837482, "A Study to Assess the Impact and Adverse Events of Topical Eyedrops of AGN-190584 on Night-driving Performance in Participants, 40 to 55 Years of Age". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04837482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*